Calliditas Therapeutics Ab ADR (CALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 91,823 | 123,785 | 111,412 | 108,597 | 79,725 |
| Receivables | 17,058 | 7,800 | N/A | N/A | 4,929 |
| Inventories | 1,926 | 361 | 104 | N/A | N/A |
| Other current assets | 1,488 | 993 | 1,323 | 2,485 | 288 |
| TOTAL | $120,247 | $139,949 | $118,089 | $113,017 | $86,876 |
| Non-Current Assets | |||||
| PPE Net | 1,514 | 740 | 736 | 18 | 11 |
| Investments And Advances | 2,282 | 1,111 | 457 | 243 | 205 |
| Intangibles | 45,202 | 47,949 | 46,572 | 50,289 | 1,700 |
| Other Non-Current Assets | 6,082 | 3,791 | 4,372 | 637 | 631 |
| TOTAL | $55,080 | $53,590 | $52,136 | $51,186 | $2,546 |
| Total Assets | $175,327 | $193,540 | $170,226 | $164,203 | $89,422 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,483 | 15,896 | 7,925 | 5,867 | 2,580 |
| Accrued Expenses | 26,463 | 13,522 | 6,244 | 4,511 | 2,700 |
| Other current liabilities | 1,866 | 2,249 | 1,481 | 1,078 | 359 |
| TOTAL | $38,394 | $32,230 | $15,793 | $11,513 | $5,647 |
| Non-Current Liabilities | |||||
| Long Term Debt | 88,596 | 70,661 | 22,057 | N/A | N/A |
| Other Non-Current Liabilities | 10,284 | 9,207 | 9,486 | 7,363 | 398 |
| TOTAL | $105,361 | $85,373 | $36,867 | $15,754 | $398 |
| Total Liabilities | $143,755 | $117,603 | $52,660 | $27,266 | $6,044 |
| Shareholders' Equity | |||||
| Common Shares | 225 | 236 | 244 | 218 | 164 |
| Retained earnings | -217,416 | -181,979 | -166,339 | -100,127 | -51,641 |
| Other shareholders' equity | -493 | 922 | -3,146 | 4,329 | -5 |
| TOTAL | $31,572 | $75,937 | $117,566 | $136,937 | $83,378 |
| Total Liabilities And Equity | $175,327 | $193,540 | $170,226 | $164,203 | $89,422 |